FDA Expedites Reviews Of Alternatives To Puerto Rico Drugs In Shortage

October 13, 2017 at 5:31 PM

FDA announced Friday (Oct. 13) that it is expediting reviews and approvals of alternative dosage forms and generic versions of multiple critical drugs facing shortages following the hurricane in Puerto Rico.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.